Effectiveness of ivermectin-based multidrug therapy in severely hypoxic, ambulatory COVID-19 patients

Aims: Ivermectin is a safe, inexpensive and effective early COVID-19 treatment validated in 20+ random, controlled trials. Having developed combination therapies for Helicobacter pylori, the authors present a highly effective COVID-19 therapeutic combination, stemming from clinical observations. Pat...

Descripción completa

Detalles Bibliográficos
Autores principales: Hazan, Sabine, Dave, Sonya, Gunaratne, Anoja W, Dolai, Sibasish, Clancy, Robert L, McCullough, Peter A, Borody, Thomas J
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Future Medicine Ltd 2022
Materias:
Short Communication
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826831/
https://www.ncbi.nlm.nih.gov/pubmed/35135310
http://dx.doi.org/10.2217/fmb-2022-0014

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8826831/
https://www.ncbi.nlm.nih.gov/pubmed/35135310
http://dx.doi.org/10.2217/fmb-2022-0014

Ejemplares similares